- Home
- VOD vs TEVA Comparison
VOD vs TEVA Comparison
Compare VOD & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOD
- TEVA
- Stock Information
- Founded
- VOD 1984
- TEVA 1901
- Country
- VOD United Kingdom
- TEVA Israel
- Employees
- VOD N/A
- TEVA N/A
- Industry
- VOD Telecommunications Equipment
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- VOD Telecommunications
- TEVA Health Care
- Exchange
- VOD Nasdaq
- TEVA Nasdaq
- Market Cap
- VOD 22.6B
- TEVA 18.4B
- IPO Year
- VOD 1988
- TEVA N/A
- Fundamental
- Price
- VOD $9.28
- TEVA $17.99
- Analyst Decision
- VOD Sell
- TEVA Strong Buy
- Analyst Count
- VOD 1
- TEVA 6
- Target Price
- VOD N/A
- TEVA $24.33
- AVG Volume (30 Days)
- VOD 14.2M
- TEVA 12.8M
- Earning Date
- VOD 05-20-2025
- TEVA 05-07-2025
- Dividend Yield
- VOD 7.69%
- TEVA N/A
- EPS Growth
- VOD N/A
- TEVA N/A
- EPS
- VOD 0.11
- TEVA N/A
- Revenue
- VOD $41,278,161,929.00
- TEVA $16,616,000,000.00
- Revenue This Year
- VOD $6.79
- TEVA $6.30
- Revenue Next Year
- VOD $3.05
- TEVA N/A
- P/E Ratio
- VOD $8.36
- TEVA N/A
- Revenue Growth
- VOD 5.15
- TEVA 3.82
- 52 Week Low
- VOD $8.00
- TEVA $12.47
- 52 Week High
- VOD $10.39
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- VOD 48.50
- TEVA 73.25
- Support Level
- VOD $9.21
- TEVA $14.17
- Resistance Level
- VOD $9.74
- TEVA $18.30
- Average True Range (ATR)
- VOD 0.12
- TEVA 0.58
- MACD
- VOD -0.03
- TEVA 0.44
- Stochastic Oscillator
- VOD 12.50
- TEVA 93.49
About VOD Vodafone Group Plc
Vodafone operates mobile and fixed-line networks and businesses in more than 20 countries. Its largest market is Germany, where it is the second mobile operator after Deutsche Telekom and owns a cable network after acquiring Kabel Deutschland in 2013 and Liberty Global Germany in 2019. In the UK it acts as a mobile operator and is attempting a merger with CK Hutchison. In 2024 Vodafone divested its Spanish and Italian divisions, given their low returns on invested capital.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.